The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field

16Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Leukotrienes (LTs) are potent biological proinflammatory mediators. LTC4, LTD4, and LTE4 are more frequently involved in chronic inflammatory responses and exert their actions binding to a cysteinyl-LT 1 (CysLT1) receptor and a cysteinyl-LT 2 (CysLT2) receptor. LTs receptor antagonists available for clinical use demonstrate high-affinity binding to the CysLT1 receptor. In this paper the employment of anti-LTs in allergic cutaneous diseases is analyzed showing that several studies have recently reported a beneficial effects of these agents (montelukast and zafirlukast as well as zileuton) for the treatment of some allergic cutaneous related diseases-like chronic urticaria and atopic eczema although their proper application remains to be established. Copyright © 2010 Eustachio Nettis et al.

Cite

CITATION STYLE

APA

Nettis, E., D’Erasmo, M., Di Leo, E., Calogiuri, G., Montinaro, V., Ferrannini, A., & Vacca, A. (2010). The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field. Mediators of Inflammation. https://doi.org/10.1155/2010/628171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free